Title
Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis
Date Issued
10 September 2016
Access level
open access
Resource Type
review
Author(s)
Rich J.D.
Beckwith C.G.
Macmadu A.
Marshall B.D.L.
Brinkley-Rubinstein L.
Amon J.J.
Milloy M.J.
King M.R.F.
Sanchez J.
Atwoli L.
Altice F.L.
Publisher(s)
Lancet Publishing Group
Abstract
The burden of HIV/AIDS and other transmissible diseases is higher in prison and jail settings than in the non-incarcerated communities that surround them. In this comprehensive review, we discuss available literature on the topic of clinical management of people infected with HIV, hepatitis B and C viruses, and tuberculosis in incarcerated settings in addition to co-occurrence of one or more of these infections. Methods such as screening practices and provision of treatment during detainment periods are reviewed to identify the effect of community-based treatment when returning inmates into the general population. Where data are available, we describe differences in the provision of medical care in the prison and jail settings of low-income and middle-income countries compared with high-income countries. Structural barriers impede the optimal delivery of clinical care for prisoners, and substance use, mental illness, and infectious disease further complicate the delivery of care. For prison health care to reach the standards of community-based health care, political will and financial investment are required from governmental, medical, and humanitarian organisations worldwide. In this review, we highlight challenges, gaps in knowledge, and priorities for future research to improve health-care in institutions for prisoners.
Start page
1103
End page
1114
Volume
388
Issue
10049
Language
English
OCDE Knowledge area
Epidemiología
Enfermedades infecciosas
Scopus EID
2-s2.0-84986288222
PubMed ID
Source
The Lancet
ISSN of the container
01406736
Sponsor(s)
This paper and The Lancet Series on HIV and Prisoners were supported by: grants to the Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health from: the National Institute on Drug Abuse; the Open Society Foundations; the United Nations Population Fund; the Johns Hopkins University Center for AIDS Research, a National Institute of Health (NIH)-funded programme (1P30AI094189). This report was also supported by: the National Institute on Drug Abuse ( K24DA022112, JDR, AM; R01DA030778, R01DA027211 DP2 DA040236, BDLM, MRFK; T32DA013911, R25DA035692, R25DA037190, LB-R; R01DA025943, R01DA029910, R01DA030768, R01DA033679, R01DA030762, R01AA018944, K24DA017072, FLA ), the National Institutes of Health ( R01DA021525, M-JM ), and by the infrastructure and resources provided by the Lifespan/Tufts/Brown Center for AIDS Research, a National Institutes of Health-funded programme ( P30AI42853, CGB ). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funders.
The institution of M-JM has received unstructured funding from National Green Biomed Ltd; this funding has partly supported his research. All other authors declare no competing interests.
Sources of information:
Directorio de Producción Científica
Scopus